Peptides
Official title: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
C07K (Peptides) appears on 129,244 US grants and 184,443 published applications in this corpus.
Search patents in C07K- Granted patents
- 129,244
- Published applications
- 184,443
- Assignees
- 30,670
- Inventors
- 230,555
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 155 | 0 |
| 1977 | 167 | 0 |
| 1978 | 244 | 0 |
| 1979 | 133 | 0 |
| 1980 | 206 | 0 |
| 1981 | 229 | 0 |
| 1982 | 233 | 0 |
| 1983 | 238 | 0 |
| 1984 | 356 | 0 |
| 1985 | 330 | 0 |
| 1986 | 366 | 0 |
| 1987 | 603 | 0 |
| 1988 | 579 | 0 |
| 1989 | 729 | 0 |
| 1990 | 626 | 0 |
| 1991 | 809 | 0 |
| 1992 | 1060 | 0 |
| 1993 | 1272 | 0 |
| 1994 | 1154 | 0 |
| 1995 | 1314 | 0 |
| 1996 | 1857 | 0 |
| 1997 | 2898 | 0 |
| 1998 | 4096 | 0 |
| 1999 | 3932 | 0 |
| 2000 | 3353 | 0 |
| 2001 | 3539 | 723 |
| 2002 | 3132 | 5449 |
| 2003 | 2934 | 9417 |
| 2004 | 2591 | 6577 |
| 2005 | 2257 | 6496 |
| 2006 | 3291 | 5967 |
| 2007 | 3305 | 5307 |
| 2008 | 3083 | 5216 |
| 2009 | 3148 | 6558 |
| 2010 | 3698 | 6503 |
| 2011 | 3580 | 6347 |
| 2012 | 3540 | 5794 |
| 2013 | 3893 | 6097 |
| 2014 | 4262 | 6716 |
| 2015 | 4311 | 6650 |
| 2016 | 4404 | 7189 |
| 2017 | 4606 | 6994 |
| 2018 | 4558 | 7487 |
| 2019 | 4930 | 8432 |
| 2020 | 5266 | 8803 |
| 2021 | 5156 | 9498 |
| 2022 | 4905 | 9789 |
| 2023 | 4454 | 9666 |
| 2024 | 4868 | 10522 |
| 2025 | 5054 | 9212 |
| 2026 | 3540 | 7034 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Main groups
- C07K 14/00Peptides having more than 20 amino acids81,438
- C07K 16/00Immunoglobulins [ig]46,944
- C07K 2317/00Immunoglobulins specific featuresIndexing code30,508
- C07K 2319/00Fusion polypeptideIndexing code27,878
- C07K 7/00Peptides having 5 to 20 amino acids in a fully defined sequence10,186
- C07K 5/00Peptides containing up to four amino acids in a fully defined sequence7,930
- C07K 1/00General methods for the preparation of peptides , i.e. processes for the7,175
- C07K 19/00Hybrid peptides , i.e. peptides covalently bound to nucleic acids, or non-covalently1,696
All 15 main groupsShow fewer
- C07K 17/00Carrier-bound or immobilised peptides1,238
- C07K 9/00Peptides having up to 20 amino acids, containing saccharide radicals and having808
- C07K 2299/00Coordinates from 3d structures of peptidesIndexing code698
- C07K 2318/00Antibody mimetics or scaffoldsIndexing code495
- C07K 2/00Peptides of undefined number of amino acids247
- C07K 11/00Depsipeptides having up to 20 amino acids in a fully defined sequence225
- C07K 4/00Peptides having up to 20 amino acids in an undefined or only162
Recent patents
- Method for providing proteinaceous composition6 Oct 2026US 12,751,468 B2Michael Foods, Inc.
- Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof6 Oct 2026US 12,751,920 B2Celestial Therapeutics, Inc.
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Cell-receptor targeted exosomes6 Oct 2026US 12,751,930 B2City of Hope
- Combination therapy of PD-1 axis binding antagonists and LRRK2 inhitibors6 Oct 2026US 12,751,956 B2Hoffmann-La Roche Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- System, method, and apparatus for bioinspired strategies for efficient light harvesting and optical processing8 Oct 2026US 2026/0305745 A1Trustees of Tufts College
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Compositions and methods for treating cancer by targeting bach18 Oct 2026US 2026/0306455 A1
Most cited
- Process for amplifying nucleic acid sequences5,960US 4,683,202 ACetus Corporation · 1987
- Recombinant immunoglobin preparations4,785US 4,816,567 AGenentech, Inc. · 1989
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Single polypeptide chain binding molecules2,454US 4,946,778 AGenex Corporation · 1990
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993